Design Therapeutics
DSGN
DSGN
88 hedge funds and large institutions have $85.5M invested in Design Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.1% less ownership
Funds ownership: 58.7% → 57.61% (-1.1%)
24% less call options, than puts
Call options by funds: $253K | Put options by funds: $335K
Holders
88
Holding in Top 10
1
Calls
$253K
Puts
$335K
Top Buyers
| 1 | +$2.73M | |
| 2 | +$2.72M | |
| 3 | +$1.93M | |
| 4 |
Goldman Sachs
New York
|
+$1.53M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.46M |
Top Sellers
| 1 | -$5.93M | |
| 2 | -$2.45M | |
| 3 | -$2.42M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.3M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$1.86M |